NVO

Sep 21, 3:15 PMNovo Nordisk's CagriSema produced greater weight loss and non-inferior blood-sugar reduction vs Eli Lilly tirzepatide 5 mg in late-stage diabetes trial

Peers: LLY AZN MRK PFE ABBV JNJ NVS BMY SNY AMGN

| Held by: PPH AVDE CNEQ WCMI PID RODM AVIV APIE OZEM AQEC

Scroll to Statements

Index	-
Market Cap	132.13B
Enterprise Value	146.69B
Income	18.19B
Sales	51.45B
Book/sh	7.66
Cash/sh	2.06
Dividend Est.	1.81 (4.58%)
Dividend TTM	1.80 (4.55%)
Dividend Ex-Date	Aug 17, 2026
Dividend Gr. 3/5Y	26.98% 19.93%
Payout	36.87%
Employees	68794
IPO	Apr 30, 1981

P/E	9.65
Forward P/E	11.76
PEG	69.15
P/S	2.57
P/B	5.16
P/C	19.21
P/FCF	11.20
EV/EBITDA	5.53
EV/Sales	2.85
Quick Ratio	0.66
Current Ratio	0.87
Debt/Eq	0.63
LT Debt/Eq	0.55
Option/Short	Yes / Yes

EPS (ttm)	4.09
EPS next Y	3.36
EPS next Q	0.76
EPS this Y	-6.16%
EPS next Y	-1.60%
EPS next 5Y	0.17%
EPS past 3/5Y	26.28% 20.36%
Sales past 3/5Y	23.19% 19.21%
EPS Y/Y TTM	12.68%
Sales Y/Y TTM	13.21%
EPS Q/Q	-18.69%
Sales Q/Q	4.59%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	24.09% 11.40%

Insider Own	0.01%
Insider Trans	0.00%
Inst Own	9.89%
Inst Trans	-0.34%
ROA	21.81%
ROE	60.35%
ROIC	34.67%
Gross Margin	80.65%
Oper. Margin	45.38%
Profit Margin	35.36%
SMA20	-11.18%
SMA50	-15.10%
SMA200	-14.28%
Trades

Shs Outstand	3.35B
Shs Float	3.35B
Short Float	0.95%
Short Ratio	2.61
Short Interest	31.65M
52W High	64.16 -38.45%
52W Low	35.12 12.45%
Volatility	2.77% 2.14%
ATR (14)	1.37
RSI (14)	30.43
Beta	0.76
Rel Volume	2.57
Avg Volume	12.12M
Volume	1,558,908

Perf Week	-7.15%
Perf Month	-15.51%
Perf Quarter	-16.72%
Perf Half Y	7.25%
Perf YTD	-22.38%
Perf Year	-34.95%
Perf 3Y	-56.75%
Perf 5Y	-21.70%
Perf 10Y	73.32%
Recom	3.20
Target Price	44.50
Prev Close	39.80
Price	39.49
Change %	-0.78%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-11-26	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$40
Aug-27-26	Downgrade	Deutsche Bank	Hold → Sell
Aug-12-26	Downgrade	Berenberg	Buy → Hold
Mar-26-26	Initiated	Wolfe Research	Peer Perform
Mar-18-26	Initiated	Bernstein	Underperform
Mar-18-26	Initiated	Bernstein	Outperform	$175
Mar-10-26	Downgrade	TD Cowen	Buy → Hold	$42
Mar-03-26	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$40
Mar-02-26	Downgrade	Goldman	Buy → Neutral	$41
Feb-24-26	Downgrade	Kepler	Buy → Hold
Feb-24-26	Downgrade	JP Morgan	Overweight → Neutral
Feb-23-26	Downgrade	Deutsche Bank	Buy → Hold
Feb-12-26	Upgrade	Jefferies	Underperform → Hold
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy

Show Previous Ratings

Today 08:22AM	Viking Therapeutics Stock Surges 36%. It Could Challenge Lilly and Novo's Obesity Empire. (Barrons.com)
08:08AM	VKTX Stock Spikes 38% Premarket: Vikings VK2735 Shows Promise For Weight-Loss Maintenance (Stocktwits)
07:29AM	GLP-1 maker Novo Nordisk's big reveal leaves the City cold (Proactive)
06:45AM	Novo Nordisk Considers Acquisitions to Expand Weight-Loss Drug Pipeline as Competition Intensifies (InvestorsHub)
01:29AM	VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 Multi-Blockbusters (Stocktwits)
03:49PM	Loading…
Sep-21-26 03:49PM	LLY Stock Gains As CEO Says Foundayo Wins One-Third Of New GLP-1 Pill Starts, Breaks Ground On $6.5B Houston Plant (Stocktwits) -7.96%
03:09PM	Lilly Gains as Novo Wins a Lower-Dose Weight-Loss Round (GuruFocus.com)
11:55AM	Novo Nordisk shares plunge over 7% as new targets fail to reassure investors (Proactive)
11:31AM	Novos Big 2030 Pitch Gets a Small Reception (Moby)
10:46AM	Novo Shares Slip as Growth Plan Disappoints Investors (Schaeffer's Research)
08:35AM	Novo Nordisk's $23B Obesity Goal Isn't Enough to Stop the Selloff (GuruFocus.com)
08:29AM	Why Novo Stock Is Dropping After Drugmaker Unveils Ambitious Growth Plan (Barrons.com)
08:26AM	Novo Nordisk Shares Sink After $23 Billion Obesity Sales Target for 2030 (GuruFocus.com)
08:20AM	Novo Nordisk Stock Drops 5.6% as 2030 Goals Match Peers (GuruFocus.com)
08:06AM	Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up (Reuters)
07:31AM	Loading…
07:31AM	Novo Nordisk Targets Over Five New Blockbusters By 2030, But NVO Stock Slides On Growth Concerns (Stocktwits)
07:20AM	Novo Nordisk stock sinks after 2030 growth plan fails to impress investors (Quartz)
07:19AM	Novo Nordisk stock falls after 2030 strategy disappoints investors (Quartz)
07:13AM	Paramount shares climb on report of negotiations, and other early market movers (MarketWatch)
06:30AM	Novo Nordisk Shares Fall 6% as Drugmaker Outlines Growth Targets Through 2030 (InvestorsHub)
05:19AM	Novo Nordisk stock gets drilled on pipeline concerns its CEO sees this as the main problem (Yahoo Finance)
04:58AM	Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals (MarketWatch)
03:37AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to climb as oil prices fall following U.S. statement that shipments through Hormuz at six-month high (MarketWatch)
12:37AM	Biotech Week Ahead: XLV Beats The Market Here Are The Stocks, Readouts And Events To Watch Next (Stocktwits)
Sep-19-26 10:30PM	What does the EU have that the U.S. does not? (Investing.com)
Sep-17-26 02:50PM	Novo Nordisk's hemophilia drug clears a key hurdle in Europe (GuruFocus.com)
02:33PM	NVO Stock Jumps 4% As European Committee Backs Novos Haemophilia Pen (Stocktwits)
08:31AM	Novo Nordisk Publishes Phase 3b Denecimig Results in Haemophilia A (InvestorsHub)
Sep-16-26 05:06PM	Novo Drops as Claude Enters Drug Development (GuruFocus.com)
12:33PM	Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal Is Betting on It. (Barrons.com)
10:16AM	Loading…
10:16AM	Novo Nordisk Scores Major AI Deal With World's Most Valuable AI Company (GuruFocus.com)
09:21AM	Novo partners with Anthropic to speed up drug development with Claude (Reuters)
09:05AM	Novo Nordisk Taps Anthropics Claude Science To Speed Up Drug Discovery Heres Everything Investors Need To Know (Stocktwits)
08:40AM	Novo Nordisk partners with Anthropic to turbocharge drug discovery (Investing.com)
08:36AM	Novo Nordisk Partners With Anthropic to Apply AI to Drug Discovery and Research (InvestorsHub)
07:59AM	Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs (Reuters)
06:44AM	NVO To Present Fresh Data From Blockbuster Wegovy Pill At European Conference As Rival Eli Lilly Readies Its Own Obesity Updates (Stocktwits)
Sep-15-26 01:13PM	FDA clears first generic radioligand drug; Sionna turns to layoffs (BioPharma Dive)
11:47AM	Novo Nordisk Stock Falls After Major Rebrand (GuruFocus.com)
08:15AM	Eli Lilly and Novo Nordisk have paid more than 270,000 doctors one as much as $1M to promote GLP-1 weight-loss drugs (Moneywise)
Sep-14-26 10:05PM	Novo Nordisk Rebrands as Novo': Stock Falls as Company Aims GLP-1s at Consumers (BeInCrypto)
02:47PM	Novo Nordisk Is Dropping Some Weight. It Still Faces a Bigger Challenge. (Barrons.com)
11:52AM	No more Nordisk: Novos latest trim is in its name (Pharmaceutical Technology)
09:20AM	Novo drops 'Nordisk' in corporate refresh to take on Lilly in the weight-loss wars (MarketWatch)
08:49AM	Novo Nordisk rebrands as Novo to compete in obesity market (Quartz)
08:13AM	Novo Nordisk Adopts Novo as Everyday Operating Name and Introduces New Cultural Framework (InvestorsHub)
05:13AM	Ozempic-maker Novo Nordisk slims down to 'Novo' (AFP)
04:51AM	NVO Stock Logs Worst Week Since February As Novo Nordisk Rebrands To Novo Amid Another Gloomy Year (Stocktwits)
04:41AM	Novo ditches Nordisk from name as drugmaker attempts revival (Financial Times)
Sep-11-26 05:10PM	Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly Competition (GuruFocus.com)
11:34AM	Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent Cliff (GuruFocus.com)
11:12AM	Novo Nordisk Stock Falls as Morgan Stanley Doubts the Offset (GuruFocus.com)
09:14AM	JPMorgan cautious on Hims & Hers on GLP-1 transition risk (Investing.com)
06:56AM	NVO Stock: Why Morgan Stanley Is Bearish On Novo Nordisk Despite Its Weight-Loss Drug Opportunity (Stocktwits)
Sep-10-26 02:13PM	Novo Stays Flat as Wegovy Wins China's First GLP-1 MASH Label (GuruFocus.com)
Sep-08-26 01:35PM	GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could Be Another Huge Market. (Barrons.com)
05:35AM	Why the CEO of Wegovy maker Novo Nordisk isn't yet sold on the peptide craze (Yahoo Finance)
05:35AM	Why CEO of Wegovy maker Novo Nordisk isn't sold yet on the peptide craze (Yahoo Finance)
Sep-07-26 01:50PM	Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial Cancellations (GuruFocus.com)
08:08AM	Novo Nordisk Semaglutide Trial Shows 40.4% of Children Moved Below Obesity BMI Threshold (InvestorsHub)
06:00AM	Weight loss is just the beginning of GLP-1's: Novo Nordisk CEO (Yahoo Finance Video)
Sep-05-26 08:30AM	Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. (MarketWatch)
Sep-04-26 01:09PM	Novo Nordisk Falls 2% as Wegovy Opens a German Front (GuruFocus.com)
Sep-02-26 10:30AM	Citi flags GLP-1 prescription slowdown at Novo Nordisk, reiterates 'sell' (Proactive)
08:05AM	Peptide innovator says the drug class is due for a rethink (Pharmaceutical Technology)
12:36AM	HIMS Stock Kicks Off September In The Red: FDAs GLP-1 Alert Steals The Spotlight From Australia Expansion (Stocktwits)
Sep-01-26 01:28PM	Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in Germany (GuruFocus.com)
05:19AM	A leadership gap looms in Nordic and Benelux boardrooms (Fortune)
Aug-31-26 06:08PM	Chris Benecchi Named Inventivas New Chief Operating Officer (Exec Edge)
08:55AM	Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market (NASDAQ: ENTX) (FinanceWire)
Aug-28-26 01:50PM	Novo's Wegovy Pill Enters China Behind Lilly (GuruFocus.com)
01:40PM	Eli Lilly's diabetes drug Mounjaro gets approval for a new use (USA TODAY)
10:12AM	Mounjaro Just Opened a Much Bigger Door (GuruFocus.com)
Aug-27-26 03:32PM	Novo Sends Oral Wegovy Into China's GLP-1 Race Behind Lilly (GuruFocus.com)
01:46PM	Novo Nordisk files for oral weight loss pill approval in China (Quartz)
01:46PM	Novo Nordisk is seeking Chinese approval for its oral weight loss pill (Quartz)
11:46AM	Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren't the Reason (Barrons.com)
09:22AM	Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip (Investing.com)
08:30AM	GLP-1 maker hit with 'sell' rating as 2027 revenue cliff fears mount (Proactive)
07:25AM	Pharmas new CEOs to watch (Pharma Voice)
07:05AM	Novos 2027 Growth Rebound Faces Fresh Doubts From Deutsche Bank Even As China Wegovy Milestone Offers Retail Hope (Stocktwits)
04:37AM	Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak (MarketWatch)
Aug-26-26 06:48AM	Boston Scientific hit by cyberattack, global operations affected (Reuters)
Aug-25-26 12:41PM	European shares gain on softer US Iran sanctions, falling oil prices (Reuters)
Aug-24-26 01:27PM	LXRX Stock Edges Higher On $10M Payout From Novo Nordisk Retail Traders Highlight More Cash Milestones On The Horizon (Stocktwits)
08:54AM	Lilly's GLP-1 pill hits UK pharmacies as US battle with Novo intensifies (Proactive)
07:13AM	Eli Lilly Launches Foundayo Weight-Loss Pill in UK (InvestorsHub)
05:47AM	Roche commits to lean-mass preservation with Hanmi obesity deal (BioPharma Dive)
05:42AM	3 potential blockbusters beyond obesity to watch (Pharma Voice)
Aug-21-26 05:50PM	SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing (Stocktwits)
Aug-19-26 06:38AM	Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy A Look At Some Key Highlights (Stocktwits)
06:30AM	HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation (TMX Newsfile)
03:28AM	How cost and perception could reshape the GLP-1 market (Pharma Voice)
Aug-18-26 11:32AM	Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors" (Investing.com)
02:17AM	Tech Weekly: soccer bots and balloon rockets (Reuters Videos)
Aug-17-26 07:01AM	Novo Nordisk AS's Dividend Analysis (GuruFocus.com)
Aug-13-26 02:38PM	Novo Nordisk Stock Slips as Pill Strategy Reframes Obesity Race (GuruFocus.com)
01:32PM	Novo Nordisk Escalates Weight-Loss War With Eli Lilly (GuruFocus.com)
Aug-12-26 10:36PM	Novo Nordisk CEO Concedes Eli Lillys Market-Share Gains as Stock Slumps (BeInCrypto)
01:29PM	Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market (GuruFocus.com)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Executive VPMr. Karsten Munk Knudsen

PresidentMr. Maziar Mike Doustdar B.A.

EVP of R&DDr. Martin Holst Lange

EVP of PeopleMs. Tania Sabroe

Executive VP of Enterprise IT & Quality and Member of Management BoardMs. Thilde Hummel Bogebjerg

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Novo Nordisk ADR

Upgrade your Finviz experience